RESUMO
Sera from human immunodeficiency virus type 1 (HIV-1)-infected and -noninfected individuals were screened for antibodies that could bind to native T cell differentiation antigens. Antibodies that could immunoprecipitate CD43 (sialophorin, leukosialin) from a T cell lymphoma line were detected in sera from 27% of patients, and antibodies that could bind specifically to transfected cells expressing CD43 were detected in 47% of patients. The anti-CD43 antibodies were related to HIV-1 infection in that no patients with other chronic viral infections or systemic lupus erythematosus contained such antibodies in their sera. The anti-CD43 autoantibodies bound to a partially sialylated form of CD43 expressed by normal human thymocytes, but not by normal, circulating T lymphocytes. However, the determinant(s) recognized by the anti-CD43 autoantibodies was present on a large proportion of circulating T lymphocytes, but masked from antibody recognition by sialic acid residues. These results demonstrate that HIV-1 infection is specifically associated with the production of autoantibodies that bind to a native T cell surface antigen.
Assuntos
Antígenos CD , Autoanticorpos/imunologia , Infecções por HIV/imunologia , HIV-1 , Sialoglicoproteínas/imunologia , Linfócitos T/imunologia , Antígenos de Superfície/análise , Linfócitos T CD4-Positivos/imunologia , Humanos , Leucossialina , Sialoglicoproteínas/análiseRESUMO
We describe an immunoadhesin molecule containing intercellular adhesion molecule 1 (ICAM-1) molecularly fused to hinge and CH2 and CH3 domains of the human immunoglobulin G1 H chain that binds Plasmodium falciparum-infected erythrocytes. This receptor-based immunoadhesin is an effective and specific inhibitor of P. falciparum-infected erythrocyte adhesion to ICAM-1-bearing surfaces, but does not inhibit leukocyte function antigen 1 (LFA-1) interaction with ICAM-1. Furthermore, the immunoadhesin promotes phagocytosis and destruction of parasitized erythrocytes by human monocytes. Each of these modes of action has potential for the therapy of malaria.
Assuntos
Moléculas de Adesão Celular/fisiologia , Eritrócitos/parasitologia , Imunoglobulina G/fisiologia , Fagocitose , Plasmodium falciparum/imunologia , Animais , Antígenos CD/fisiologia , Sequência de Bases , Antígenos CD36 , Humanos , Molécula 1 de Adesão Intercelular , Dados de Sequência MolecularRESUMO
Blast-1 is a human activation-associated glycoprotein expressed on the surface of leukocytes. Analysis of a translated sequence from a Blast-1 cDNA reveals a single hydrophobic sequence which could traverse the plasma membrane, but is devoid of charged residues that might represent a cytoplasmic tail. Consistent with this characteristic, Blast-1 is demonstrated here to be anchored to the cell surface through a glycosyl-phosphatidylinositol (GPI)-containing lipid. Comparison of Blast-1 to other GPI-anchored membrane proteins revealed a striking primary and secondary structure similarity with MRC OX45 and the lymphocyte function antigen LFA-3. The degree of overall amino acid sequence homology reveals that OX45 is a rat homologue of Blast-1. The greatest homology to LFA-3 occurs between their NH2-terminal Ig-like domains. Evidence is presented that demonstrates that Blast-1 and LFA-3 possess a disulfide-bonded second domain. These common characteristics demonstrate a structural and evolutionary relationship between Blast-1, OX45, LFA-3, and CD2, which in turn suggests a functional role for Blast-1 in cell-cell interactions in the immune response. The gene for Blast-1 has been localized to chromosome 1 q21-q23, indistinguishable from the CD1 cluster of Ig superfamily genes, raising the possibility that they may be linked.
Assuntos
Antígenos de Superfície , Cromossomos Humanos Par 1 , Glicolipídeos/análise , Glicoproteínas de Membrana , Fosfatidilinositóis/análise , Sequência de Aminoácidos , Animais , Antígenos CD , Antígeno CD48 , Antígenos CD58 , Linhagem Celular Transformada , Mapeamento Cromossômico , Cricetinae , Glicosilação , Glicosilfosfatidilinositóis , Humanos , Ativação Linfocitária/efeitos dos fármacos , Dados de Sequência Molecular , Hibridização de Ácido Nucleico , Fosfatidilinositóis/metabolismo , Fito-Hemaglutininas/farmacologia , Conformação Proteica , Homologia de Sequência do Ácido Nucleico , Linfócitos T/análise , Fosfolipases Tipo C/metabolismoRESUMO
The beta2 family of integrins, CD11a, CD11b, CD11c, and alphad, are expressed on most leukocytes. We show that the newest member of this family, alphad, is expressed on human eosinophils in peripheral blood, and surface expression can be upregulated within minutes by phorbol ester or calcium ionophore A23187. Culture of eosinophils with interleukin 5 (IL-5) leads to a two- to fourfold increase in alphad levels by 3-7 d without a change in alpha4 integrin expression. Eosinophils isolated from late phase bronchoalveolar lavage fluids express alphad at levels similar to that seen after 3 d of IL-5 culture. Regarding alphadbeta2 ligands, in both freshly isolated and IL-5-cultured eosinophils, as well as alphadbeta2-transfected Chinese hamster ovary cells, alphadbeta2 can function as a ligand for vascular cell adhesion molecule 1 (VCAM-1). This conclusion is based on the ability of monoclonal antibodies to alphad, beta2, or VCAM-1 to block cell attachment in static adhesion assays. In experiments with eosinophils, the relative contribution of alphadbeta2 integrin- mediated adhesion is enhanced after IL-5 culture. These experiments demonstrate that alphadbeta2 is an alternative ligand for VCAM-1, and this integrin may play a role in eosinophil adhesion to VCAM-1 in states of chronic inflammation.
Assuntos
Eosinófilos/metabolismo , Integrinas/metabolismo , Receptores de Citoadesina , Molécula 1 de Adesão de Célula Vascular/metabolismo , Animais , Antígenos CD11 , Adesão Celular , Cricetinae , Eosinófilos/citologia , Eosinófilos/imunologia , Humanos , Cadeias alfa de Integrinas , LigantesRESUMO
We have studied the cytoskeletal association of intercellular adhesion molecule-1 (ICAM-1, CD54), an integral membrane protein that functions as a counterreceptor for leukocyte integrins (CD11/CD18). A linkage between ICAM-1 and cytoskeletal elements was suggested by studies showing a different ICAM-1 staining pattern for COS cells transfected with wild-type ICAM-1 or with an ICAM-1 construct that replaces the cytoplasmic and transmembrane domains of ICAM-1 with a glycophosphatidylinositol (GPI) anchor. Wild-type ICAM-1 appeared to localize most prominently in microvilli whereas GPI-ICAM-1 demonstrated a uniform cell surface distribution. Disruption of microfilaments with cytochalasin B (CCB) changed the localization of wild-type ICAM-1 but had no effect on GPI-ICAM-1. Some B-cell lines demonstrated a prominent accumulation of ICAM-1 into the uropod region whereas other cell surface proteins examined were not preferentially localized. CCB also induced redistribution of ICAM-1 in these cells. For characterization of cytoskeletal proteins interacting with ICAM-1, a 28-residue peptide that encompasses the entire predicted cytoplasmic domain (ICAM-1,478-505) was synthesized, coupled to Sepharose-4B, and used as an affinity matrix. One of the most predominant proteins eluted either with soluble ICAM-1,478-505-peptide or EDTA, was 100 kD, had a pI of 5.5, and in Western blots reacted with alpha-actinin antibodies. A direct association between alpha-actinin and ICAM-1 was demonstrated by binding of purified alpha-actinin to ICAM-1,478-505-peptide and to immunoaffinity purified ICAM-1 and by a strict colocalization of ICAM-1 with alpha-actinin, but not with the cytoskeletal proteins talin, tensin, and vinculin. The region of ICAM-1,478-505 interacting with alpha-actinin was mapped to the area close to the membrane spanning region. This region contains several positively charged residues and appears to mediate a charged interaction with alpha-actinin which is not highly dependent on the order of the residues.
Assuntos
Actinina/metabolismo , Actinas/metabolismo , Moléculas de Adesão Celular/metabolismo , Citoesqueleto/metabolismo , Sequência de Aminoácidos , Animais , Linfócitos B/metabolismo , Linhagem Celular , Linhagem Celular Transformada , Citocalasina B/farmacologia , Citoplasma/metabolismo , Imunofluorescência , Glicolipídeos/metabolismo , Glicosilfosfatidilinositóis , Humanos , Molécula 1 de Adesão Intercelular , Linfócitos/metabolismo , Dados de Sequência Molecular , Fosfatidilinositóis/metabolismo , Células Tumorais CultivadasRESUMO
Vascular cell adhesion molecule 1 (VCAM-1), a member of the Ig superfamily originally identified on activated endothelium, binds to the integrin very late antigen-4 (VLA-4), also known as alpha 4 beta 1 or CD49d/CD29, to support cell-cell adhesion. Studies based on cell adhesion to two alternatively spliced forms of VCAM-1 or to chimeric molecules generated from them and intercellular adhesion molecule-1 (ICAM-1) have demonstrated two VLA-4 binding sites on the predominate form of VCAM-1. Here, we studied VLA-4-dependent adhesion of the lymphoid tumor cell line Ramos to cells expressing wild type and mutant forms of VCAM-1. Results based on domain deletion mutants demonstrated the existence and independence of two VLA-4-binding sites located in the first and fourth domains of VCAM-1. Results based on amino acid substitution mutants demonstrated that residues within a linear sequence of six amino acids found in both domain 1 and 4 were required for VLA-4 binding to either domain. Five of these amino acids represent a conserved motif also found in ICAM domains. We propose that integrin binding to these Ig-like domains depends on residues within this conserved motif. Specificity of integrin binding to Ig-like domains may be regulated by a set of nonconserved residues distinct from the conserved motif.
Assuntos
Moléculas de Adesão Celular/metabolismo , Receptores de Antígeno muito Tardio/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Moléculas de Adesão Celular/química , Primers do DNA/química , Humanos , Molécula 1 de Adesão Intercelular , Camundongos , Dados de Sequência Molecular , Ligação Proteica , Proteínas Recombinantes de Fusão/metabolismo , Deleção de Sequência , Relação Estrutura-Atividade , Molécula 1 de Adesão de Célula VascularRESUMO
While the leukocyte integrin lymphocyte function-associated antigen (LFA)-1 has been demonstrated to bind intercellular adhesion molecule (ICAM)-1, results with the related Mac-1 molecule have been controversial. We have used multiple cell binding assays, purified Mac-1 and ICAM-1, and cell lines transfected with Mac-1 and ICAM-1 cDNAs to examine the interaction of ICAM-1 with Mac-1. Stimulated human umbilical vein endothelial cells (HUVECs), which express a high surface density of ICAM-1, bind to immunoaffinity-purified Mac-1 adsorbed to artificial substrates in a manner that is inhibited by mAbs to Mac-1 and ICAM-1. Transfected murine L cells or monkey COS cells expressing human ICAM-1 bind to purified Mac-1 in a specific and dose-dependent manner; the attachment to Mac-1 is more temperature sensitive, lower in avidity, and blocked by a different series of ICAM-1 mAbs when compared to LFA-1. In a reciprocal assay, COS cells cotransfected with the alpha and beta chain cDNAs of Mac-1 or LFA-1 attach to immunoaffinity-purified ICAM-1 substrates; this adhesion is blocked by mAbs to ICAM-1 and Mac-1 or LFA-1. Two color fluorescence cell conjugate experiments show that neutrophils stimulated with fMLP bind to HUVEC stimulated with lipopolysaccharide for 24 h in an ICAM-1-, Mac-1-, and LFA-1-dependent fashion. Because cellular and purified Mac-1 interact with cellular and purified ICAM-1, we conclude that ICAM-1 is a counter receptor for Mac-1 and that this receptor pair is responsible, in part, for the adhesion between stimulated neutrophils and stimulated endothelial cells.
Assuntos
Antígenos CD/fisiologia , Moléculas de Adesão Celular/fisiologia , Antígeno de Macrófago 1/metabolismo , Receptores Imunológicos , Anticorpos Monoclonais , Adesão Celular/fisiologia , Cromatografia de Afinidade , Endotélio Vascular/metabolismo , Humanos , Molécula 1 de Adesão Intercelular , Antígeno-1 Associado à Função Linfocitária/isolamento & purificação , Antígeno-1 Associado à Função Linfocitária/metabolismo , Antígeno de Macrófago 1/isolamento & purificação , Neutrófilos/metabolismo , TransfecçãoRESUMO
The expression, tissue distribution, and preliminary characterization of a cell surface molecule, apparently a glycolipid, recognized by a monoclonal antibody, anti-PAA, were described. This antibody (anti-PAA) was produced by the fusion of myeloma cells NS-1 with spleen cells from a BALB/c mouse, which were sensitized with activated human T-cells generated by allogeneic stimulation in mixed-lymphocyte culture (MLC). Resting human peripheral blood T-cells, B-cells, and monocytes demonstrated weak anti-PAA binding. Binding of proliferating T-cells (phytohemagglutinin- and MLC-activated T-cells) and thymocytes to anti-PAA was two to six times greater than that of resting T-cells. A fifteenfold-increased binding was observed with acute lymphocytic leukemia T-cell lines. Epstein-Barr virus-transformed B-cell lines bound anti-PAA up to sixteenfold greater than resting B-cells. Tumor cell lines of various nonlymphoid origins demonstrated marked reactivity with this antibody. Both benign and malignant cells in hyperplastic tissues, of various origins, bound anti-PAA, whereas their normal, nonproliferating counterparts did not. Normal proliferating cells in these tissues, including cells of the placental chorionic villi and trophoblasts, also bound anti-PAA. Of all lymphoid and nonlymphoid cell lines examined, only chronic lymphocytic leukemia (CLL) cells and some cell lines derived from Burkitt's lymphoma showed weak or no binding. This antibody also failed to react with a variety of nonprimate cell lines. Anti-PAA antibody did not immunoprecipitate any protein from lymphoid tumor cell lines to which it demonstrated a quantitatively high degree of binding, nor did protease treatment of these lines decrease antibody binding. Anti-PAA did, however, bind to glycolipids extracted from these cell lines. Binding of this monoclonal antibody to a minor neutral glycolipid, isolated from the erythroleukemia cell line K562, was about sixfold greater than that of any other K562 neutral glycolipid or ganglioside. Anti-PAA demonstrated weak or undetectable binding to purified, predominant, lymphoid cell membrane's neutral glycolipids and gangliosides. The monoclonal antibody anti-PAA appeared, therefore, to recognize a unique, proliferation-associated, neutral glycolipid present on normal as well as on benign and malignant proliferating cells. The antigen appeared to be universally expressed on proliferating cells from all human tissues with the exception of some Burkitt's cell lines and CLL cells. Nonhuman cell lines, except those for closely related primates, did not express PAA.
Assuntos
Divisão Celular , Anticorpos Monoclonais , Antígenos de Neoplasias , Antígenos de Superfície , Linhagem Celular , Transformação Celular Neoplásica , Cromatografia em Camada Fina , Ensaio de Imunoadsorção Enzimática , Glicolipídeos/metabolismo , Glicoesfingolipídeos/metabolismo , Humanos , Técnicas Imunoenzimáticas , Ativação Linfocitária , Linfócitos/metabolismo , Neoplasias/metabolismoRESUMO
Intercellular adhesion molecule 1 (ICAM-1), a member of the immunoglobulin gene superfamily, is a cell surface glycoprotein with an extracellular domain comprising five immunoglobulin-like domains. Soluble ICAM-1, a recombinant protein truncated at the transmembrane domain, has a rod-like shape, 19 nm long overall, with a characteristic bend 7.6 nm from one end of the molecule. Because the link between domain D2 and domain D3 is proline rich, it has been proposed that the short arm contains domains D1 and D2 and the long arm contains domains D3-D5. We used single-molecule electron microscopy of soluble ICAM-1 decorated with monoclonal antibodies specific for domains D1 and D4 to show that the bend instead lies between domains D3 and D4. Therefore, the short arm lies closer to the plasma membrane, whereas the long arm, containing all the known ligand binding sites on ICAM-1, is positioned toward the target cell surface.
Assuntos
Moléculas de Adesão Celular/química , Complexo Antígeno-Anticorpo/química , Humanos , Molécula 1 de Adesão Intercelular , Substâncias Macromoleculares , Microscopia Eletrônica , Conformação ProteicaRESUMO
Although it is well known that the expression of major histocompatibility complex (MHC) antigens on the surface of lymphoblastoid cell lines are cell cycle dependent, the way in which the MHC antigen expression on activated T cells varies with cell cycle phase has not previously been described. Using 11 lymphoblastoid cell lines from malignant and nonmalignant tissues (B cells, T cells, and myeloid cells) and five activated T cell lines (two cell lines activated by phytohemagglutinin and three alloreactive T cell clones), MHC antigen expression was quantitatively studied by dual-beam flow cytometry. Correlated measurements of surface antigen quantity (immunofluorescence), DNA content (Hoechst 33342), and cell size (light scatter), uninfluenced by induction synchrony and cell fixation, were performed. The data indicate that cell surface antigen quantity and cell surface area demonstrate specific values at each phase of the cell cycle when the cells are in logarithmic growth. Examining cells in logarithmic growth, it was confirmed, for all lymphoblastoid cell lines, that the quantity of MHC antigens on G2 (S + G2 + M) cells was greater than that on G1 cells. In addition, it was found, by analyzing antigen quantity and surface area, that class I antigen density in the G2 phase is 17% less than that in the G1 phase in leukemic T cell lines, and that both class I and class II antigen densities in the G2 phase were 21% less than that in the G1 phase in lymphoblastoid B cell lines. In activated T cells, class I antigen density in the G2 phase was 11% less than that in the G1 phase, while class II antigen density in the G2 phase was 12% greater than that in the G1 phase. We describe four important observations in this report. In both G1 and G2 phases, activated T cells express: quantitatively fewer class I antigens than lymphoblastoid B cell lines; similar quantity of class I antigens as that of leukemic T cell lines; and similar quantity of class II antigens as that of lymphoblastoid B cell lines. Also, class II antigens are expressed in greater density in the G2 phase than in the G1 phase in activated T cells. In contrast, lymphoblastoid B cell lines express greater density of class II antigens in the G1 phase than in the G2 phase of the cell cycle. These findings differ from previous reports, suggesting that G1 phase cells may have a more significant role than G2 phase cells as target cells for MHC restricted cytotoxic cells.
Assuntos
Linfócitos B/imunologia , Antígenos HLA/análise , Linfócitos T/imunologia , Linfócitos B/efeitos dos fármacos , Ciclo Celular , Linhagem Celular , DNA/análise , Teste de Cultura Mista de Linfócitos , Fito-Hemaglutininas/farmacologia , Linfócitos T/efeitos dos fármacos , Fatores de TempoRESUMO
The intercellular adhesion molecule 1 (ICAM-1) is used as cellular receptor by 90% of human rhinoviruses (HRV). Recently, a recombinant, soluble ICAM-1 (sICAM-1) has been shown to be effective in prevention of the cytopathic effect of rhinovirus infection in vitro. Aim of this study was the production of molecules with multivalent binding sites. Different chimeric proteins were constructed by fusion of two or five extracellular domains of ICAM-1 with the constant regions of IgA1, IgM and IgG1 by polymerase chain reactions (PCR). IgA- and IgG-immunoadhesion molecules were expressed in eucaryotic cells as dimers, IgM-immunoadhesion molecules as decamers. Immunoadhesion molecules were compared to sICAM-1 for their ability to neutralize HRV: The chimeric protein of five N-terminal domains of ICAM-1 and the constant regions of IgA1 was 150 times more potent than sICAM-1 in neutralizing HRV. The first and the second N-terminal of ICAM-1 fused to IgA1 or IgM were five times more active, however, fused to IgG1 four times less active than sICAM-1. Sedimentation analyses of [H3]-leucin labled HRV after preincubation with the different immunoadhesion molecules showed a dose-dependent induction of a conformational change of the viral capsid proteins. The order of efficiency of the chimeric proteins was consistent to the neutralizing experiments. Our results showed that HRV neutralizing can be dramatically increased by multimerization of ICAM-1. The chimeric molecule between IgA1 and ICAM-1 seems to be a potential candidate for clinical testing to prevent and treat HRV-infections.
Assuntos
Moléculas de Adesão Celular/farmacologia , Efeito Citopatogênico Viral/efeitos dos fármacos , Imunoglobulinas/farmacologia , Proteínas Recombinantes de Fusão/farmacologia , Rhinovirus/efeitos dos fármacos , Relação Dose-Resposta a Droga , Humanos , Molécula 1 de Adesão Intercelular , Receptores Virais/efeitos dos fármacos , Relação Estrutura-AtividadeAssuntos
Adesão Celular , Leucócitos/fisiologia , Glicoproteínas de Membrana , Receptores de Superfície Celular , Animais , Anticorpos Monoclonais/uso terapêutico , Antígenos de Diferenciação/deficiência , Antígenos de Diferenciação/genética , Antígenos de Diferenciação/fisiologia , Antígenos de Superfície/fisiologia , Moléculas de Adesão Celular , Movimento Celular , Cães , Humanos , Síndromes de Imunodeficiência/genética , Síndromes de Imunodeficiência/patologia , Inflamação , Integrina alfaXbeta2 , Antígeno-1 Associado à Função Linfocitária , Antígeno de Macrófago 1 , Glicoproteínas de Membrana/deficiência , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/fisiologia , Camundongos , Estrutura Molecular , Fagocitose , Coelhos , Receptores de Superfície Celular/genética , Receptores de Superfície Celular/fisiologia , Receptores de Complemento/metabolismo , Receptores de Complemento 3bRESUMO
Blast-1 is an early activation-associated glycoprotein expressed on the surface of human lymphocytes. Here we report the isolation and analysis of a cDNA encoding Blast-1. The translated sequence of the Blast-1 cDNA contains a hydrophobic putative signal peptide and a hydrophobic carboxyl terminus devoid of charged residues. The sequence also contains five N-linked glycosylation sites, the utilization of which was confirmed by the shift in relative mol. wt of Blast-1 upon digestion with N-glycosidase F. The translated sequence reveals that Blast-1 is related to members of the immunoglobulin superfamily, especially to CD4 and MHC class II molecules. The homology to these proteins is greatest in their amino termini where they demonstrate 30-32% identity. This region of Blast-1 also demonstrated 25% identity to a V kappa sequence. Considering conservative amino acid substitutions this homology to CD4, MHC class II and V kappa becomes 60, 49 and 48%, respectively.
Assuntos
Antígenos de Diferenciação de Linfócitos B/genética , Clonagem Molecular , Ativação Linfocitária , Sequência de Aminoácidos , Sequência de Bases , Linhagem Celular , DNA/isolamento & purificação , Enzimas de Restrição do DNA , Genes , Humanos , Dados de Sequência Molecular , Biossíntese de Proteínas , Homologia de Sequência do Ácido Nucleico , Transcrição GênicaRESUMO
CD43 is a cell-surface sialoglycoprotein of uncertain physiologic function expressed to various degrees by most leukocytes. We tested whether or not CD43 participates in intercellular adhesion by comparing the binding of human T lymphocytes to transfected HeLa cells stably expressing CD43 and sham-transfected HeLa cells (CD43-negative). Significantly fewer T lymphocytes adhered to the CD43-positive HeLa cells than to the CD43-negative HeLa cells. Diminished T-cell adherence to the CD43-positive HeLa cells was seen for all T lymphocytes tested, irrespective of their source or derivation. Antibody-blocking experiments revealed that CD43 interference with T-cell adhesion largely represented interference with T-cell leukocyte function-associated antigen 1 binding to HeLa cell intercellular adhesion molecule 1. The CD43 anti-adhesion effect was not overcome by treating cells with phorbol 12-myristate 13-acetate, a chemical that increases the binding avidity of leukocyte function-associated antigen 1 for intercellular adhesion molecule 1. However, neuraminidase treatment of the HeLa cell transfectants diminished the CD43 antiadhesion effect. These data indicate that CD43 expression by opposing cells can interfere with cell-cell adhesion. The data also suggest that CD43 might regulate T-cell adhesion by interfering with leukocyte function-associated 1 binding to intercellular adhesion molecule 1, a major activation-induced adhesion pathway among lymphocytes.
Assuntos
Antígenos CD , Adesão Celular , Sialoglicoproteínas/fisiologia , Linfócitos T/citologia , Moléculas de Adesão Celular/fisiologia , Células HeLa , Humanos , Técnicas In Vitro , Leucossialina , Ativação Linfocitária , Antígeno-1 Associado à Função Linfocitária/metabolismo , Neuraminidase/farmacologia , TransfecçãoRESUMO
The leukocyte adhesion molecule LFA-1 mediates a wide range of lymphocyte, monocyte, natural killer cell, and granulocyte interactions with other cells in immunity and inflammation. LFA-1 (CD11a/CD18) is a receptor for intercellular adhesion molecule 1 (ICAM-1, CD54), a surface molecule which is constitutively expressed on some tissues and induced on other in inflammation. Induction of ICAM-1 on epithelial cells, endothelial cells and fibroblasts mediates LFA-1-dependent adhesion of lymphocytes. Several lines of evidence have suggested the existence of a second LFA-1 ligand: homotypic adhesion of one cell line was inhibited by a monoclonal antibody to LFA-1, but not by one to ICAM-1; there exists an LFA-1-dependent, ICAM-1-independent pathway of adhesion to endothelial cells; and also, there are some types of target cells in which LFA-1-dependent T-lymphocyte adhesion and lysis are independent of ICAM-1. We have cloned this second ligand, designated ICAM-2, using a novel method for identifying ligands of adhesion molecules. ICAM-2 is an integral membrane protein with two immunoglobulin-like domains, whereas ICAM-1 has five. Remarkably, ICAM-2 is much more closely related to the two most N-terminal domains of ICAM-1 (34% identity) than either ICAM-1 or ICAM-2 is to other members of the immunoglobulin superfamily, demonstrating the existence of a subfamily of immunoglobulin-like ligands that bind the same integrin receptor.
Assuntos
Antígenos CD , Antígenos de Diferenciação/metabolismo , Antígenos de Superfície/genética , Clonagem Molecular , Sequência de Aminoácidos , Anticorpos Monoclonais , Antígenos de Superfície/imunologia , Sequência de Bases , Adesão Celular , Moléculas de Adesão Celular , Linhagem Celular , DNA/genética , Ácido Edético , Vetores Genéticos , Antígeno-1 Associado à Função Linfocitária , Glicoproteínas de Membrana , Dados de Sequência Molecular , Hibridização de Ácido Nucleico , Plasmídeos , RNA Mensageiro/análise , RNA Mensageiro/genética , Homologia de Sequência do Ácido Nucleico , TransfecçãoRESUMO
L-selectin mediates the initial contact of leukocytes with the endothelium prior to extravasation. Here we demonstrate that L-selectin engagement can induce rapid and avid integrin-dependent T cell adhesion to recombinant immobilized cell adhesion molecules (CAMs) including ICAM-1, ICAM-3, and VCAM-1, as well as to the extracellular matrix protein fibronectin (FN). L-selectin-induced adhesion to these integrin ligands shares characteristics with CD3 mAb- or phorbol ester-induced adhesion in requiring metabolic energy, tyrosine kinase and ligand-stimulated Ca2+ channel activity. However, L-selectin-induced adhesion is distinct from that induced by phorbol ester or CD3 crosslinking in being relatively independent of protein kinase C (PKC) activity and actin polymerization. Consistent with the higher levels of L-selectin expression on CD45RA+ (naive) cells, L-selectin crosslinking induces a greater proportion of naive relative to memory cell binding to CAMs and FN. In contrast, exposure to phorbol ester or CD3 crosslinking is more effective in inducing CD45RO+ (memory) cell adhesion. Thus, in addition to its role in leukocyte capture and rolling on the endothelium, L-selectin may contribute to beta 1 and beta 2 integrin-dependent binding and arrest.
Assuntos
Adesão Celular/fisiologia , Integrinas/metabolismo , Selectina L/metabolismo , Transdução de Sinais , Subpopulações de Linfócitos T/fisiologia , Adesão Celular/efeitos dos fármacos , Moléculas de Adesão Celular/metabolismo , Reagentes de Ligações Cruzadas , Citocalasina D , Metabolismo Energético , Inibidores Enzimáticos/farmacologia , Humanos , Hidroquinonas/farmacologia , Proteína Quinase C/antagonistas & inibidores , Proteínas Tirosina Quinases/antagonistas & inibidoresRESUMO
Leukocyte adhesion to endothelium and extravasation are dynamic processes that require activation of integrins. Chemoattractants such as IL-8 and FMLP are potent activators of leukocyte integrins. To compare the chemoattractant-stimulated activation of three integrins, alpha 4 beta 7, alpha L beta 2, and alpha V beta 3, in the same cellular context, we expressed an IL-8 receptor (IL-8RA) and FMLP receptor (FPR) in the lymphoid cell line JY. Chemoattractants induced a rapid increase in alpha L beta 2- and alpha V beta 3-dependent JY adhesion within 5 min, and it was sustained for 30 min. In contrast, stimulation of alpha 4 beta 7-dependent adhesion was transient, returning to basal levels by 30 min. The activation profiles of the integrins were similar regardless of whether IL-8 or FMLP was used for induction. We also demonstrate that alpha 4 beta 7-dependent adhesion was uniquely responsive to the F actin-disrupting agent cytochalasin D and the protein kinase C (PKC) inhibitor chelerythrin. While alpha V beta 3- and alpha L beta 2-mediated cell adhesion was significantly reduced by cytochalasin D, alpha 4 beta 7-mediated adhesion was enhanced. Chelerythrin inhibited both the IL-8 and PMA activation of alpha L beta 2 and alpha V beta 3. In contrast, inducible alpha 4 beta 7 activity was unaffected, and basal activity was increased. These findings demonstrate that the mechanism of alpha 4 beta 7 regulation by chemoattractants is different from that of alpha L beta 2 and alpha V beta 3 and that it appears to involve distinct cytoskeletal and PKC dependencies. In addition, PKC activity may be a positive or negative regulator of integrin-dependent adhesion.
Assuntos
Integrinas/metabolismo , Interleucina-8/farmacologia , Antígeno-1 Associado à Função Linfocitária/metabolismo , N-Formilmetionina Leucil-Fenilalanina/farmacologia , Receptores de Vitronectina/metabolismo , Antígenos CD/biossíntese , Linfócitos B , Adesão Celular/efeitos dos fármacos , Linhagem Celular Transformada , Citocalasina D/farmacologia , Humanos , Integrinas/efeitos dos fármacos , Integrinas/fisiologia , Interleucina-8/metabolismo , Antígeno-1 Associado à Função Linfocitária/efeitos dos fármacos , Antígeno-1 Associado à Função Linfocitária/fisiologia , N-Formilmetionina Leucil-Fenilalanina/metabolismo , Proteína Quinase C/fisiologia , Receptores de Formil Peptídeo , Receptores Imunológicos/biossíntese , Receptores de Interleucina/biossíntese , Receptores de Interleucina-8A , Receptores de Peptídeos/biossíntese , Receptores de Vitronectina/efeitos dos fármacos , Receptores de Vitronectina/fisiologia , Transfecção/imunologiaRESUMO
We have identified a novel cytoplasmic protein, leupaxin, that is preferentially expressed in hematopoietic cells and is most homologous to the focal adhesion protein, paxillin. Leupaxin possesses two types of protein interaction domains. There are four carboxyl-terminal LIM domains in leupaxin that share 70% amino acid identity and 80% similarity with those in paxillin. Paxillin LIM domains mediate localization to focal contacts. In the amino-terminal region of leupaxin there are three short stretches of approximately 13 amino acids that share 70-90% similarity with paxillin LD motifs. Paxillin LD motifs have been implicated in focal adhesion kinase (FAK) and vinculin binding resulting in the localization of FAK to focal adhesions. Leupaxin is expressed in cell types, such as macrophage, that lack FAK. We demonstrate here that leupaxin associates with a second FAK family member, PYK2. As leupaxin and PYK2 are both preferentially expressed in leukocytes they may therefore form a cell type-specific signaling complex. We also demonstrate that leupaxin is a substrate for a tyrosine kinase in lymphoid cells and thus may function in and be regulated by tyrosine kinase activity. Leupaxin is thus a phosphotyrosine protein with LD and LIM binding motifs most homologous to paxillin that may assemble and regulate PYK2 signaling complexes in leukocytes.
Assuntos
Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular/fisiologia , Adesão Celular , Fosfoproteínas/fisiologia , Proteínas Tirosina Quinases/metabolismo , Sequência de Aminoácidos , Sequência Consenso , Citoplasma/metabolismo , Proteínas do Citoesqueleto/química , DNA Complementar/genética , Quinase 2 de Adesão Focal , Células-Tronco Hematopoéticas/metabolismo , Humanos , Tecido Linfoide/metabolismo , Macrófagos/química , Dados de Sequência Molecular , Paxilina , Fosfoproteínas/química , Fosfoproteínas/metabolismo , Ligação Proteica , Homologia de Sequência de Aminoácidos , Transdução de Sinais , Distribuição TecidualRESUMO
Both the integrins LFA-1 and Mac-1 bind to ICAM-1, an immunoglobulin superfamily member. Previously, we localized the binding sites of LFA-1 and the major group of human rhinoviruses to the first NH2-terminal immunoglobulin-like domain of ICAM-1. Here, we show that the binding site on ICAM-1 for Mac-1 is unexpectedly distinct from that for LFA-1 and maps to the third NH2-terminal immunoglobulin-like domain. These findings provide a function for the tandem duplication of immunoglobulin-like domains in ICAM-1 and have implications for other immunoglobulin superfamily members. Mutations at two sites in the third domain that destroy consensus sequences for N-linked glycosylation enhance binding to purified Mac-1. Agents that interfere with carbohydrate processing provide evidence that the size of the N-linked oligosaccharide side chains on ICAM-1 affects binding to Mac-1 but not to LFA-1. Thus, we suggest that the extent of glycosylation on ICAM-1 may regulate adhesion to LFA-1 or Mac-1 in vivo.
Assuntos
Moléculas de Adesão Celular/metabolismo , Antígeno de Macrófago 1/metabolismo , Sequência de Aminoácidos , Sítios de Ligação , Adesão Celular , Análise Mutacional de DNA , Glicoproteínas/metabolismo , Glicosilação , Humanos , Técnicas In Vitro , Molécula 1 de Adesão Intercelular , Antígeno-1 Associado à Função Linfocitária/metabolismo , Neutrófilos/citologia , Ligação Proteica , Proteínas Recombinantes/metabolismo , Relação Estrutura-AtividadeRESUMO
Intercellular adhesion molecule 1 (ICAM-1) is a 90 kd inducible surface glycoprotein that promotes adhesion in immunological and inflammatory reactions. ICAM-1 is a ligand of lymphocyte function-associated antigen-1 (LFA-1), an alpha beta complex that is a member of the integrin family of cell-cell and cell-matrix receptors. ICAM-1 is encoded by an inducible 3.3 kb mRNA. The amino acid sequence specifies an integral membrane protein with an extracellular domain of 453 residues containing five immunoglobulin-like domains. Highest homology is found with neural cell adhesion molecule (NCAM) and myelin-associated glycoprotein (MAG), which also contain five Ig-like domains. NCAM and MAG are nervous system adhesion molecules, but unlike ICAM-1, NCAM is homophilic. The ICAM-1 and LFA-1 interaction is heterophilic and unusual in that it is between members of the immunoglobulin and intergrin families. Unlike other integrin ligands, ICAM-1 does not contain an RGD sequence.